Quest Diagnostics has announced the launch of an at-home Covid-19 rapid antigen test service offered for consumer purchase through its consumer-initiated testing platform, QuestDirect. 

In partnership with eMed, the latest service includes proctored telehealth, which features a trained technician to ensure correct sample collection, verify identity and certify the reported results during the telehealth visit.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The offering allows the Abbott BinaxNOW COVID-19 Ag Card Home Test to be used under the supervision of a certified telehealth proctor and an eMed laboratory report to be provided to the user.

These reports could be used for international travel, confirming positive results to facilitate prescription treatment by a doctor and return to work or school programmes in settings where proctored Covid-19 tests are needed.

Each test comes with certified telehealth proctoring which can be used at any time and from anywhere in the world. 

Adults and children from the age of four years can use the self-administered nasal swab antigen test, which delivers results in 15 minutes.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Quest Diagnostics clinical franchise solutions and marketing senior vice-president and group executive Cathy Doherty said: “Consumers and employers seek reliable, fast and easy testing solutions to help limit exposure to Covid-19 and ensure safer travelling and return to work. 

“This QuestDirect offering complements our molecular laboratory testing services to increase access, convenience and flexibility to diagnostic insights. 

“As a leader in the nation’s Covid-19 testing response, Quest Diagnostics is continually looking to broaden access to quality Covid-19 diagnostic insights, and this collaboration with eMed expands our ability to help individuals across the US meet the challenge of Covid-19.”

Furthermore, the company is partnering with digital health firm Truepill to fulfil and deliver orders.

Due to the API-connected digital health platform and countrywide pharmacy footprint of Truepill, users will be able to obtain test kits within two to three business days of purchase.

In April 2020, Quest and Centene collaborated to extend real-time reverse transcription-polymerase chain reaction Covid-19 testing across the US.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact